Changes in the glutamate biomarker expression in rats vulnerable or resistant to the rewarding effects of cocaine and their reversal by ceftriaxone.
Amino Acid Transport Systems, Acidic
/ metabolism
Animals
Biomarkers, Pharmacological
/ metabolism
Brain
/ drug effects
Ceftriaxone
/ metabolism
Cocaine
/ metabolism
Cocaine-Related Disorders
/ metabolism
Drug-Seeking Behavior
/ drug effects
Excitatory Amino Acid Transporter 2
/ genetics
Gene Expression Regulation
/ genetics
Glutamic Acid
/ genetics
Male
NF-E2-Related Factor 2
/ genetics
NF-kappa B
/ genetics
Nucleus Accumbens
/ drug effects
Rats
Rats, Wistar
Reward
Self Administration
Ceftriaxone
Cocaine addiction
GLT-1
Glutamate
Nf-κB
Nrf2
xCT
Journal
Behavioural brain research
ISSN: 1872-7549
Titre abrégé: Behav Brain Res
Pays: Netherlands
ID NLM: 8004872
Informations de publication
Date de publication:
16 09 2019
16 09 2019
Historique:
received:
20
02
2019
revised:
11
05
2019
accepted:
13
05
2019
pubmed:
18
5
2019
medline:
31
7
2020
entrez:
18
5
2019
Statut:
ppublish
Résumé
Literature data show diverse vulnerability to the rewarding effects of cocaine in human as well as in laboratory animals. The molecular mechanisms of these differences have not been discovered yet. While the initial effects of cocaine depend primarily on the dopamine system, numerous studies have shown that adaptation within the glutamatergic system is responsible for the development of addiction. In this paper, we used the unbiased conditioned place preference (CPP) to identify rats showing a vulnerable or resistant phenotype to the rewarding effects of cocaine. Next, we investigated the expression of membrane glutamate transporter proteins: GLT-1 and xCT in selected brain structures in the above-mentioned groups of rats. Moreover, we determined the nuclear level of NF-κB and Nrf2 to verify whether changes in GLT-1 and xCT expression correlate with NF-κB and Nrf2 levels, respectively. In addition, we determined GLT-1, NF-κB, xCT and Nrf2 mRNA levels to verify the involvement of transcriptional mechanisms. We also analyzed the ability of the β-lactam antibiotic, ceftriaxone, to attenuate the persistence of CPP after a cocaine-free period in animals showing vulnerability to cocaine rewarding effects, and furthermore we determined GLT-1, xCT, NF-κB and Nrf2 protein expression. Our findings demonstrated molecular and neurochemical differences in the response to cocaine administration that are characteristic of the phenotype vulnerable or resistant to the rewarding effects of cocaine. Moreover, repeated administrations of ceftriaxone during cocaine-free perios attenuated CPP persistence and normalized GLT-1 level in the NAc. The results suggest the a lack of NF-κB involvement in the regulation of GLT-1 expression by ceftriaxone in the NAc. Additionally, we are the first to report that ceftriaxone strongly upregulates the GLT-1 in the HIP in a transcriptional mechanism involving the Nf-κB transcription factor. Future experiments may resolve the question concerning whether modulation exclusively of the GLT-1 expression in the HIP may attenuate cocaine-induced place preference or relapse.
Identifiants
pubmed: 31100299
pii: S0166-4328(19)30280-3
doi: 10.1016/j.bbr.2019.111945
pii:
doi:
Substances chimiques
Amino Acid Transport Systems, Acidic
0
Biomarkers, Pharmacological
0
Excitatory Amino Acid Transporter 2
0
NF-E2-Related Factor 2
0
NF-kappa B
0
Nfe2l2 protein, rat
0
Slc1a2 protein, rat
0
Glutamic Acid
3KX376GY7L
Ceftriaxone
75J73V1629
Cocaine
I5Y540LHVR
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
111945Informations de copyright
Copyright © 2019 Elsevier B.V. All rights reserved.